Sulfobromophthalein disodium salt hydrate
SIAL/S0252 - used to study hepatocyte transport functions
Synonym: BSP; Bromsulfalein sodium disodium salt hydrate
CAS Number: 123359-42-2
Empirical Formula (Hill Notation): C20H8Br4Na2O10S2 · xH2O
Molecular Weight: 838.00 (anhydrous basis)
EC Number: 200-761-0
MDL Number: MFCD00150017
Linear Formula: C20H8Br4Na2O10S2 · xH2O
Product Type: Chemical
| λmax | 575-581 nm |
| application(s) | diagnostic assay manufacturing hematology histology |
| color | white to light gray |
| composition | Water (by Karl Fischer): ≤ 8% Sodium (Na) anhydrous: 4.6-5.8% |
| form | powder |
| InChI | 1S/C20H10Br4O10S2.2Na.H2O |
| InChI key | CDTNUNQQEUGDSD-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | [Na+].[Na+].[H]O[H].Oc1cc |
| solubility | water: 50 mg/mL, clear to hazy |
| storage temp. | room temp |
| technique(s) | titration: suitable |
| Application: | Sulfobromophthalein disodium salt hydrate has been used as a positive control to study the interaction of 11-keto-β-boswellic acid (KBA) and 3-acetyl-11-keto-β-boswellic acid (AKBA) with organic anion transporter OATP1B3. |
| Biochem/physiol Actions: | Sulfobromophthalein (BSP) is a high affinity organic ion substrate for organic anion transporting polypeptides (OATPs) and has been used as a substrate for multidrug resistance associated protein 2 (Mrp2). BSP is transported into hepatocytes by OATPs and, after conjugation to glutathione, is excreted into bile by Mrp2. It was found to inhibit the aldo-keto reductase ARK1C20. |
| Packaging: | 5 g in glass bottle |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H317 - H334 |
| Precautionary statements | P261 - P280 - P342 + P311 |
| Hazard Codes | Xn |
| Risk Statements | 42/43 |
| Safety Statements | 22-36/37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | room temp |
| UNSPSC | 12171500 |


